Literature DB >> 15260382

Does hypnotizability affect human upright stance?

E L Santarcangelo1, C Rendo, J Carpaneto, P Dario, S Micera, G Carli.   

Abstract

Subjects highly (Highs) and low susceptible to hypnosis (Lows) show different imagery and attentional capabilities and also peculiar somatomotor, vegetative and electroencephalographic differences in basal and task conditions. Since attention is one of the main component of hypnotic susceptibility and also a relevant factor for postural control, the aim of the experiment was to study actual differences between Highs and Lows at the eyes closure during upright stance. Visual and motor imagery as well as attentional/disattentional capabilities were evaluated through psychological tests. Posture was monitored though Elite systems during upright stance with open and closed eyes. At the eyes closure, Highs and Lows exhibited a different body sway modulation. Possible different compensation mechanisms are suggested for the two groups and interactions between attentional/arousal systems responsible of hypnotic phenomenology and postural control are underlined.

Entities:  

Mesh:

Year:  2004        PMID: 15260382

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  3 in total

1.  Hypnotizability-dependent modulation of postural control: effects of alteration of the visual and leg proprioceptive inputs.

Authors:  Enrica Laura Santarcangelo; E Scattina; G Carli; A Macerata; D Manzoni
Journal:  Exp Brain Res       Date:  2008-08-16       Impact factor: 1.972

2.  Imagery of different sensory modalities: hypnotizability and body sway.

Authors:  G Carli; F I Cavallaro; C A Rendo; Enrica L Santarcangelo
Journal:  Exp Brain Res       Date:  2006-11-14       Impact factor: 2.064

3.  Hypnosis-induced modulation of corticospinal excitability during motor imagery.

Authors:  Paola Cesari; Michele Modenese; Sara Benedetti; Mehran Emadi Andani; Mirta Fiorio
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.